Ir al contenido principal

Eventos

11 – 15 May 2026
ASGCT Annual Meeting
Boston, EEUU
ASGCT Annual Meeting
22 – 25 Jun 2026
Bio International Convention
San Diego, EEUU
Bio International Convention
07 – 09 Sep 2026
Advanced Therapies Europe
Barcelona, España
29 – 01 Oct 2026
BIOSPAIN
Bilbao, España
05 – 07 Oct 2026
Cell and Gene Meeting on the Mesa
Phoenix, EEUU
07 – 09 Oct 2026
Bio Japan
Yokohama, Japón
27 – 30 Oct 2026
ESGCT Annual Congress
Hamburgo, Alemania
04 – 05 Nov 2026
Advanced Therapies EEUU
Boston, EEUU
06 – 09 May 2026
ISCT Annual Meeting
Dublín, Irlanda
ISCT Annual Meeting
ISCT Annual Meeting

Presentación del póster número 979 Scalable Cell Detachment Process Enabling Direct Seeding of Large-Scale 200 m2 and 600 m2 Bioreactors, el 6 de mayo, de 19h a 20:30h, en el nivel 4 del auditorio.

28 – 30 Abr 2026
Cell and Gene Meeting on the Med
Roma, Italia
28 – 30 Abr 2026
BIO KOREA
Seúl, Korea
BIO KOREA

Expositor, stand L6

17 – 18 Mar 2026
Advanced Therapies UK
Londres, Reino Unido
Advanced Therapies UK
Advanced Therapies UK
09 – 12 Feb 2026
Advanced Therapies Week
San Diego, EEUU
Advanced Therapies Week

Bronze Sponsor, stand 638

Presentación corporativa en la Innovation Zone, 10 de febrero, 13:30h

01 – 03 Dic 2025
Cell & Gene Therapy International Europe
Berlín, Alemania
07 – 10 Oct 2025
ESGCT Annual Congress
Sevilla, España
ESGCT Annual Congress

Expositor, stand D31

02 – 04 Sep 2025
Advanced Therapies Europe
Barcelona, España
Advanced Therapies Europe

Expositor, stand nº 26

16 – 19 Jun 2025
Bio International Convention
Boston, EEUU
13 – 16 May 2025
ASGCT Annual Meeting
Nueva Orleans, EEUU
ASGCT Annual Meeting

· Expositor, stand nº 1927
· Presentación en el Tools and Technology Forum, mié. 14 de mayo, 15h – 15:15h

05 – 06 May 2025
Swiss Biotech Day
Basilea, Suiza
15 – 17 Abr 2025
Cell and Gene Meeting on the Med
Roma, Italia
Cell and Gene Meeting on the Med
18 – 19 Mar 2025
Advanced Therapies Congress
Londres, Reino Unido
18 – 20 Mar 2025
Bioprocessing Summit Europe
Barcelona, España

Presentación de póster A35 Establishment and characterization of a stable producer cell line generation platform for the manufacturing of clinical-grade lentiviral vectors.